Study identifies predictors of acquired von Willebrand diseaseDecember 26, 2017Lymphoma & Plasma Cell Disorders
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 21, 2017Neuro-oncologyPatient & Survivor Care
FDA approves cabozantinib for the frontline treatment of advanced RCCDecember 21, 2017Renal Cell Carcinoma
FDA: Gadolinium retention prompts new GBCA class warning, safety measuresDecember 20, 2017Patient & Survivor CareNeuro-oncologyCNS/Brain Cancer
FDA: Laparoscopic power morcellators can spread malignant cells when used in women with occult uterine cancers*December 19, 2017Gynecologic Cancer
Sequential chemotherapy and radiotherapy may be best in locally advanced NSCLC with negative marginsDecember 19, 2017Lung Cancer
Postmenopausal women who shed pounds see lower breast cancer riskDecember 18, 2017Breast CancerPreventive Care
CRB-410 update: Multiple myeloma response rates remain high with bb2121 CAR T-cell therapyDecember 15, 2017Immuno-oncology
VIDEO - New lymphoma drug approvals: Clinical use, future directionsDecember 14, 2017Lymphoma & Plasma Cell DisordersImmuno-oncologyFollicular Lymphoma
